2024-07-15 13:01:09 ET
Summary
- Today, we circle back to diagnostic testing concern CareDx, Inc for the first time in 2024.
- The stock has moved up some 60% since the company delivered better than expected quarterly results in early May.
- The company has appointed a new CEO and seen some certainty around a key patent litigation lawsuit so far this year as well.
- Can the rally continue, or is the stock overdue for some profit taking? An updated analysis follows in the paragraphs below.
Today, we are taking our first look at CareDx, Inc ( CDNA ) in 2024. The company has seen a lot of news flow over the past couple of months, and it is to sift through recent events and results to review our take around this healthcare diagnostic concern. An updated analysis follows in the paragraphs below....
Read the full article on Seeking Alpha
For further details see:
CareDx: Benefiting From Some Certainty